» Articles » PMID: 15452232

Disruption of Kaposi's Sarcoma-associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence

Overview
Journal J Virol
Date 2004 Sep 29
PMID 15452232
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Latent nuclear antigen (LNA) is implicated in Kaposi's sarcoma-associated herpesvirus (KSHV) episome persistence. LNA colocalizes with KSHV episomes on chromosomes in metaphase, and it maintains the stability and replication of KSHV terminal repeat-containing plasmids. In this study, we examined the function of LNA in episome persistence in the context of full-length KSHV genome by mutagenesis analysis. We generated a KSHV mutant, BAC36-DeltaLNA, with LNA disrupted by transposon-based mutagenesis with a KSHV BAC clone, BAC36, as a template. Immunofluorescence antibody staining revealed that the insertion of a transposon cassette into LNA disrupted its expression but had no effect on the expression of two adjacent genes, the vCyclin and vFLIP genes. Using a green fluorescent protein (GFP) cassette as a tracking marker for the KSHV episome, we found 8.7-fold-fewer GFP-positive cells in BAC36-DeltaLNA cultures than in wild-type BAC36 cultures at the early stage following episome delivery into 293 cells by transfection, which could be partially rescued by cotransfection with a LNA expression plasmid but not a control plasmid. Cells harboring BAC36-DeltaLNA with or without transient complementation rapidly lost episomes and became virus-free after 2 weeks of culture based on GFP expression and Gardella gel analysis and quantitative PCR assays for detecting KSHV genomes. In contrast, BAC36 episomes were stably maintained during the same period. Stable cultures with close to 100% of cells harboring KSHV episomes were readily established by hygromycin selection for BAC36 but not for BAC36-DeltaLNA. These results conclusively indicate that LNA is essential for the establishment and persistence of KSHV episomes in mammalian cells.

Citing Articles

Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis.

Chen L, Ding L, Wang X, Huang Y, Gao S mBio. 2023; 15(1):e0301123.

PMID: 38117084 PMC: 10790708. DOI: 10.1128/mbio.03011-23.


Herpesvirus-induced spermidine synthesis and eIF5A hypusination for viral episomal maintenance.

Choi U, Lee J, Park A, Jung K, Lee S, Choi Y Cell Rep. 2022; 40(7):111234.

PMID: 35977517 PMC: 9494279. DOI: 10.1016/j.celrep.2022.111234.


How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell.

Sugden A, Hayes M, Sugden B Viruses. 2021; 13(8).

PMID: 34452344 PMC: 8402831. DOI: 10.3390/v13081478.


Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.

Ju E, Li T, Ramos da Silva S, Markazi A, Gao S J Med Virol. 2021; 93(8):5065-5075.

PMID: 33942339 PMC: 9016784. DOI: 10.1002/jmv.27046.


Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism.

Calderon A, Soldan S, De Leo A, Deng Z, Frase D, Anderson E Oncotarget. 2020; 11(46):4224-4242.

PMID: 33245718 PMC: 7679036. DOI: 10.18632/oncotarget.27815.


References
1.
Viejo-Borbolla A, Kati E, Sheldon J, Nathan K, Mattsson K, Szekely L . A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol. 2003; 77(12):7093-100. PMC: 156177. DOI: 10.1128/jvi.77.12.7093-7100.2003. View

2.
Watanabe T, Sugaya M, Atkins A, Aquilino E, Yang A, Borris D . Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells. J Virol. 2003; 77(11):6188-96. PMC: 155023. DOI: 10.1128/jvi.77.11.6188-6196.2003. View

3.
Gao S, Deng J, Zhou F . Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol. 2003; 77(18):9738-49. PMC: 224610. DOI: 10.1128/jvi.77.18.9738-9749.2003. View

4.
Pan H, Zhang Y, Wang X, Deng J, Zhou F, Gao S . Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol. 2003; 77(18):9758-68. PMC: 224565. DOI: 10.1128/jvi.77.18.9758-9768.2003. View

5.
Grundhoff A, Ganem D . Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest. 2004; 113(1):124-36. PMC: 300762. DOI: 10.1172/JCI17803. View